61 related articles for article (PubMed ID: 1768058)
1. Spontaneous endometrial hyperplasia. The prognostic significance of steroid receptor concentration. A two year follow-up of patients treated with abrasio only.
Lindahl B; Fernö M; Norgren A; Willen R
Anticancer Res; 1991; 11(5):1875-7. PubMed ID: 1768058
[TBL] [Abstract][Full Text] [Related]
2. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.
Lindahl B; Alm P; Fernö M; Norgren A
Anticancer Res; 1990; 10(3):725-30. PubMed ID: 2142394
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
Lindahl B; Willén R
Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
[TBL] [Abstract][Full Text] [Related]
5. [Hormone receptor status in adenomatous hyperplasia of the endometrium and endometrial carcinoma].
Martin R; Lehmann E; Leitsmann H
Zentralbl Gynakol; 1990; 112(16):1031-8. PubMed ID: 2220177
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous endometrial hyperplasia. A 5 year follow-up of 82 patients after high-dose gestagen treatment.
Lindahl B; Willén R
Anticancer Res; 1994; 14(6B):2831-4. PubMed ID: 7872726
[TBL] [Abstract][Full Text] [Related]
7. Endometrial hyperplasia following estrogen treatment without the addition of gestagen. A follow-up study after withdrawal of estrogens.
Lindahl B; Willén R
Anticancer Res; 1991; 11(6):2071-3. PubMed ID: 1776842
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor expression and HER-2/neu (c-erbB-2) oncoprotein in the uterus of cats with cystic endometrial hyperplasia-pyometra complex.
Misirlioglu D; Nak D; Sevimli A; Nak Y; Ozyigit MO; Akkoc A; Cangul IT
J Vet Med A Physiol Pathol Clin Med; 2006 Jun; 53(5):225-9. PubMed ID: 16737511
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
10. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
Lindahl B; Willén R
Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
[TBL] [Abstract][Full Text] [Related]
11. [The formulation of the current management of patients with atypical hyperplasia (AH)].
Gorchev G; Milkov V; Popov I; Rachev E
Akush Ginekol (Sofiia); 1993; 32(3):30-1. PubMed ID: 8037315
[TBL] [Abstract][Full Text] [Related]
12. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
13. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
14. Steroid receptor concentrations as a prognostic factor in atypical endometrial hyperplasia.
Lindahl B; Willén R
Anticancer Res; 1998; 18(5B):3793-5. PubMed ID: 9854498
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
Lindahl B; Alm P
Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
18. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy.
Fernandez MD; Alaghband-Zadeh J; Burn JI
Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
20. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]